NEWARK, NJ — University Hospital, New Jersey’s state-owned public hospital, received the top designation for its liver transplant program on Monday, distinguishing it as the leader in one-year survival rate.
The Scientific Registry of Transplant Recipients awarded the status to the University Hospital Center for Advanced Liver Diseases and Transplantation, which boasts above a 98% survival rate. The program is led by physicians at Rutgers New Jersey Medical School.
“Being ranked as a top facility by the SRTR affirms that we are one of the top liver transplant programs in the entire nation,” said Dr. Nikolaos Pyrsopoulos, Medical Director of the Liver Transplant Program at University Hospital. “The SRTR ranking broadens our profile and enhances the awareness of University Hospital, and our partners at Rutgers New Jersey Medical School, to the larger world.”
University Hospital’s program shares the designation with Beth Israel Deaconess Medical Center in Boston, MA, a teaching subsidiary of Harvard Medical School with the same survival rate.
“People already know University Hospital as a leading academic medical center and the Level 1 Trauma Center for Northern New Jersey. We are honored by this recognition and pleased to add the liver transplant program as another point of pride for the institution,” said Dr. James V. Guarrera, Chief of Service – Surgery and Program and Surgical Director of Liver Transplantation at University Hospital.
The Center for Advanced Liver Diseases and Transplantation, ranking out of 61 nationally, was established in 1989 as the first of its kind the state. It has performed more than 1,500 liver transplant surgeries, 80 of which were executed in the last two years.
“This designation reinforces our position as one of the outstanding liver transplant centers in the country, and reinforces our role as New Jersey’s public hospital and a northeast healthcare powerhouse,” said Shereef Elnahal, President and CEO of University Hospital. “Lives are literally being saved because of the Center for Advanced Liver Diseases and Transplantation, the leadership of Drs. Pyrsopoulos and Guarrera, our dedicated team members, and the active support of our partners at Rutgers New Jersey Medical School.”